The effect of Herceptin on the growth of nasopharyngeal carcinoma cell lines with HER-2/neu gene overexpressionGU Kang-sheng, GUAN Zhong-Zhen, LI Zhi-ming, HOU Jing-hui, HE Li-rong225-229
α-Melanocyte-stimulating hormone induces apoptosis in malignant melanoma cellsLI Li, XING Xin, XUE Chun-yu, Zhang Jing-de230-234
Development of quality of life questionnaire for cancer patients QLQ-52 and the evaluation of questionnaire's qualityLIU Fu-an, YU Shi-ying235-239
The clinical and pathological significance of the expression to BVI and LVI in NSCLC tissueLI Hong-sheng, WANG Yuan-dong, GAN You-yun, TAN Xiao-jun, ZHAO Qian, XIAO Liu-zhen, LAO Shu-zhen240-242
Gefitinib in patients with advanced refractory small cell lung cancer contemporaneous with superior vena cava syndromeQIAN Jun, QIN Shu-kui, TANG Qing-qing, CHEN Ying-xia, YANG Liu-qing243-244
The elementary report of a clinical study on the relationship between the expression of C-erbB-2 or p53 and the efficacy of the neuadjuvant chemotherapy in the patients with lung adenocarcinomaLIU Xi-guang, SUN Xian-lu, WANG Yong-jie, LIANG Jun, LEI Wei, LIU Hua-min245-248
Clinical analysis of chemotherapy increases the risk of hepatic toxicity in hepatitis B virus antigen positive patients with lung cancerLUO Jie, ZHENG Di, ZHOU Cai-cun249-251
The clinical comparison of taxotere or vinorelbine combined with cisplatin in the treatment of advanced non-small cell lung cancerLIU Min-zhi, CHEN Ying-lan, Deng Jin-yun, WANG Di-jin, XU Yan-liang252-254
Clinical analysis of 70 cases of advanced esophageal carcinoma without dysphagiaZHU Ya-fang, WEI Jin-zhi255-256,259
The clinical study of continuous intravenous infusion vinorelbine with cisplatin for advanced esophageal cancerQIAN Zhi-yin, HE Liu257-259